GCG and obesity due to melanocortin 4 receptor deficiency: In the context of gut peptides, current anti‐obesity medications primarily involve drugs that target the incretin hormones glucagon‐like peptide‐1 (GLP‐1) and gastric inhibitory polypeptide (GIP).25, 26